An update on vascular calcification and potential therapeutics

Area of Science:

• Cardiovascular Medicine
• Nephrology
• Biochemistry

Background:

• Pathological calcification is a primary driver of cardiovascular morbidities, particularly in individuals with chronic kidney disease (CKD), end-stage renal disease (ESRD), and metabolic disorders.
• Vascular calcification is an active, cell-mediated process influenced by metabolic insults like diabetes, hypertension, dyslipidemia, and atherosclerosis, rather than a passive event.

Purpose of the Study:

• To review the intricate relationship between vascular calcification and associated clinical diseases.
• To identify key regulators and genetic factors contributing to pathological calcification.
• To explore novel therapeutic avenues and drug development for preventing and reversing vascular calcification.

Main Methods:

• Literature review focusing on cellular mechanisms of calcification.
• Analysis of various factors inducing vascular calcification, including bone formation, apoptosis, and Ca-P balance.
• Examination of current and emerging interventions targeting calcification.

Main Results:

• Vascular calcification involves complex mechanisms such as induced bone formation, apoptosis, altered calcium-phosphorus balance, and loss of inhibitory factors.
• Numerous interventions are under investigation, including phosphate binders, vitamin K, calcimimetics, vitamin D, bisphosphonates, and TNAP inhibitors.
• Genetic factors have been identified as contributors to pathological calcification.

Conclusions:

• Current preventive measures for pathological calcification are limited.
• Targeting cellular mechanisms offers promising avenues for developing new drugs and treatment strategies.
• Further research is needed to develop effective treatments for reversing or curing pathological calcification.